Language:

Results 1 - 20 of 380 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Refined by: Database: Journals@Ovid Open Access Journal Collection Rolling

Database: Wiley-Blackwell Open Access Titles

Open Access: Nature Open Access

Result Number	Material Type	Record Details and Options
1	Material Type: Article	The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities Clinical & translational immunology, 2023, Vol.12 (6), p.e1454-n/a [Peer Reviewed Journal] 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2023 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1454 ;PMID: 37337612 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
2	Material Type: Article	Epstein–Barr virus infection, B‐cell dysfunction and other risk factors converge in gut‐associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesis Clinical & translational immunology, 2022, Vol.11 (11), p.e1418-n/a [Peer Reviewed Journal] 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1418 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	Material Type: Article	Genetic risk for severe COVID‐19 correlates with lower inflammatory marker levels in a SARS‐CoV‐2‐negative cohort Clinical & Translational Immunology, 2021, Vol.10 (6), p.e1292-n/a [Peer Reviewed Journal] 2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1292 ;PMID: 34141432 Digital Resources/Online E-Resources View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	Lessons from ten years of genome‐wide association studies of asthma Clinical & translational immunology, 2017-12, Vol.6 (12), p.e165-n/a [Peer Reviewed Journal] 2017 The Authors ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2017 The Author(s) 2017 The Author(s) ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1038/cti.2017.54 ;PMID: 29333270 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	Epstein–Barr virus and multiple sclerosis: the dawn of a new age Clinical & translational immunology, 2023, Vol.12 (6), p.e1457-n/a [Peer Reviewed Journal] 2023 The Author. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1457 ;PMID: 37383181 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population Clinical & translational immunology, 2019, Vol.8 (2), p.e1043-n/a [Peer Reviewed Journal] 2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australasian Society for Immunology Inc. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1043 ;PMID: 30788107 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
7	Material Type: Article	Proteome‐wide analysis of T‐cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile Clinical & translational immunology, 2020, Vol.9 (1), p.e01102-n/a [Peer Reviewed Journal] 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. ;2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1102 ;PMID: 31956413 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
8	Material Type: Article	Cardiovascular disease in SARS‐CoV‐2 infection Clinical & Translational Immunology, 2021, Vol.10 (9), p.e1343-n/a [Peer Reviewed Journal] 2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1343 ;PMID: 34512975 Digital Resources/Online E-Resources View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
9	Material Type: Article	Landscape of T‐cell repertoires with public COVID‐19‐associated T‐cell receptors in pre‐pandemic risk cohorts Clinical & Translational Immunology, 2021, Vol.10 (9), p.e1340-n/a [Peer Reviewed Journal] 2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc ;2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1340 ;PMID: 34484739 Digital Resources/Online E-Resources View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	Severe COVID‐19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals Clinical & translational immunology, 2022, Vol.11 (4), p.e1365-n/a [Peer Reviewed Journal] 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc ;2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1365 ;PMID: 35444807 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	Material Type: Article	Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity Clinical & translational immunology, 2023, Vol.12 (6), p.e1456-n/a [Peer Reviewed Journal] 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2023 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1456 ;PMID: 37383182 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	Material Type: Article	Clinical immune‐monitoring strategies for predicting infection risk in solid organ transplantation Clinical & translational immunology, 2014-02, Vol.3 (2), p.e12-n/a [Peer Reviewed Journal] 2014 The Authors ;2014. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2014 Australasian Society for Immunology Inc. 2014 Australasian Society for Immunology Inc. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1038/cti.2014.3 ;PMID: 25505960 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	Risk stratification biomarkers for Staphylococcus aureus bacteraemia Clinical & translational immunology, 2020, Vol.9 (2), p.e1110-n/a [Peer Reviewed Journal] 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. ;2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1110 ;PMID: 32082571 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	T-cell response after first dose of BNT162b2 SARS-CoV-2 vaccine among healthcare workers with previous infection or cross-reactive immunity Clinical & translational immunology, 2021-01, Vol.10 (9), p.e1341-e1341 [Peer Reviewed Journal] 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1341 ;PMID: 34522381 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation Clinical & translational immunology, 2024, Vol.13 (1), p.e1484-n/a [Peer Reviewed Journal] 2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2024 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1484 ;PMID: 38223258 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	Material Type: Article	Is the risk of cardiovascular disease altered with anti‐inflammatory therapies? Insights from rheumatoid arthritis Clinical & translational immunology, 2016-05, Vol.5 (5), p.e84-n/a [Peer Reviewed Journal] 2016 The Authors ;2016. This work is published under http://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2016 Australasian Society for Immunology Inc. 2016 Australasian Society for Immunology Inc. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1038/cti.2016.31 ;PMID: 27350883 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
17	Material Type: Article	Recent novel approaches to limit oxidative stress and inflammation in diabetic complications Clinical & translational immunology, 2018, Vol.7 (4), p.e1016-n/a [Peer Reviewed Journal] 2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australasian Society for Immunology Inc. ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1016 ;PMID: 29713471 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
18	Material Type: Article	Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response Clinical & Translational Immunology, 2020, Vol.9 (12), p.e1217-n/a [Peer Reviewed Journal] 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1217 ;PMID: 33376594 Digital Resources/Online E-Resources View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
19	Material Type: Article	Deficient DNASE1L3 facilitates neutrophil extracellular traps‐induced invasion via cyclic GMP‐AMP synthase and the non‐canonical NF‐κB pathway in diabetic hepatocellular carcinoma Clinical & translational immunology, 2022, Vol.11 (4), p.e1386-n/a [Peer Reviewed Journal] 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1386 ;PMID: 35474906 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
20	Material Type: Article	Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery Clinical & translational immunology, 2022, Vol.11 (1), p.e1368-n/a [Peer Reviewed Journal] 2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-0068 ;EISSN: 2050-0068 ;DOI: 10.1002/cti2.1368 ;PMID: 35079378 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by